BDBM516577 US11053243, Example 189a::methyl [(2S)-1-{(2S)-2-[5-(10- {2-[(2S)-1-{(2S)-2- [(methoxycarbonyl)amino]-3- methylbutanoyl}pyrrolidin-2-yl]- 1H-imidazol-5-yl}indolo[1,2-c] [1,3]benzoxazin-3-yl)-1H- imidazol-2-yl]pyrrolidin-1-yl}-3- methyl-1-oxobutan-2- yl]carbamate

SMILES COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc2-c3cc4cc(ccc4n3COc2c1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C

InChI Key InChIKey=UKOFBQYBTQKOPR-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516577   

TargetGenome polyprotein(HCV)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM516577(US11053243, Example 189a | methyl [(2S)-1-{(2S)-2-...)
Affinity DataEC50:  0.150nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent